It looks like on Merck's website they are currently recruiting for a couple CRC trials. I will admit that I have no idea if these are the same types of trials we are looking to run.

Does anyone know how much the trial that they just finished cost them? I would imagine these trials are more expensive than the one we had planned for inflammation based on how Dr. JL talked about it. If that's the case, then that's pretty good evidence that he expects a bunch of money to be coming from somewhere. Could be a partner, could be NIH, and could even be that we are expecting Amarex to sign a settlement soon. I don't know if I particularly care where the money is coming from as long as it allows us to start moving forward again. Any reason we should prefer one of those sources over the others?